Our goal is to address serious medical conditions across multiple and diverse therapeutic areas. Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries.
AUTHORIZED FOR EMERGENCY USE ONLY
Casirivimab and imdevimab are investigational therapies and have been authorized by FDA for emergency use. Casirivimab and imdevimab must be administered together. Casirivimab and imdevimab are not FDA approved for any use.
Safety and effectiveness of casirivimab and imdevimab have not been fully established. This emergency use authorization is only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.